Renaud Bio Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.51 Cr
as on 16-11-2024
- Satisfied Charges ₹ 1.90 Cr
as on 16-11-2024
- Revenue 10.42%
(FY 2023)
- Profit 2.48%
(FY 2023)
- Ebitda 79.95%
(FY 2023)
- Net Worth 7.00%
(FY 2023)
- Total Assets 4.46%
(FY 2023)
About Renaud Bio
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.51 Cr. The company has closed loans amounting to ₹1.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kotireddy Mukku, Jyoshna Annapureddy, and Bhargavi Meegada serve as directors at the Company.
- CIN/LLPIN
U74999TG2016PTC111609
- Company No.
111609
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Aug 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Renaud Bio Private Limited offer?
Renaud Bio Private Limited offers a wide range of products and services, including Vials and Ampoules, Glass Vials, Packing Seals, PTFE Silicone Septa, Packaging Caps & Seals, Drills, Grinders, Saws & Power Tools, Air Blowers & Guns.
Who are the key members and board of directors at Renaud Bio?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kotireddy Mukku  | Managing Director | 23-Aug-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jyoshna Annapureddy | Director | 23-Aug-2016 | Current |
| Bhargavi Meegada | Director | 23-Aug-2016 | Current |
Financial Performance of Renaud Bio.
Renaud Bio Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.42% increase. The company also saw a slight improvement in profitability, with a 2.48% increase in profit. The company's net worth moved up by a moderate rise of 7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renaud Bio?
In 2023, Renaud Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 23 Jul 2024 | ₹1.00 Cr | Open |
Canara Bank Creation Date: 28 Jun 2024 | ₹4.60 M | Open |
Others Creation Date: 26 Mar 2024 | ₹3.05 Cr | Open |
How Many Employees Work at Renaud Bio?
Renaud Bio has a workforce of 17 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renaud Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renaud Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
